SOL Group (SOL) investor relations material

Executive summary

• Consolidated net sales reached €948.6 million in H1 2026, up 8.5% year-over-year, driven by organic expansion, M&A activity, and growth in both technical gases and home care segments.

• EBITDA rose to €247.4 million (26.1% margin), up 12.1%, and EBIT increased to €148.8 million (15.7% margin), reflecting improved operational efficiency.

• Home Care segment outperformed with 11.3% revenue growth and a 12.9% increase in patients served year-over-year.

• Technical Gases segment posted a 5.5% revenue increase, maintaining stable EBITDA margins.

• Growth was supported by geographic expansion, acquisitions, and an increased patient base in home care.

Financial highlights

• Group revenues reached €948.6 million in H1 2026, up from €874.1 million in H1 2025.

• EBITDA rose to €247.4 million (26.1% margin), and EBIT to €148.8 million (15.7% margin).

• Net profit for the period was €89.9 million, up 7.6% year-over-year, with a margin at 9.5%.

• EPS reached €0.991, up from €0.921 year-over-year.

• CAPEX (excluding M&A) increased to €93.3 million, with total investments and acquisitions at €172.5 million in H1 2026.

Outlook and guidance

• Continued focus on organic growth, targeted acquisitions, and readiness to pursue further strategic partnerships.

• Emphasis on diversification and reinforcement in key markets through M&A.

• Ongoing monitoring of geopolitical and energy market volatility.